盧美哌隆對(duì)甲苯磺酸鹽Lumateperone Tosylate

一、產(chǎn)品概述

Lumateperone是由百時(shí)美施貴寶研發(fā)的一種小分子藥物，是一種5-HT2A拮抗劑和DRD2拮抗劑。2019年12月20日，Lumateperone獲得美國(guó)食品藥品管理局FDA批準(zhǔn)，由Intra-Cellular Therapies Inc銷(xiāo)售，商品名為Caplyta^?。

二、主要產(chǎn)品

Description	Structural Formula	CAS No.	Category
Lumateperone Tosylate		1187020-80-9	API
4aS,9bR)-6-Bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole   (S)-2-Hydroxy-2-phenylacetate		1059630-13-5	intermediates
(6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline   dihydrochloride		2339905-28-9	intermediates
4-chloro-1-(4-fluorophenyl)butan-1-one		41167-07-1   or 3874-54-2	intermediates

Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.